查看購物車
  • Simplified Chinese
  • English
歐洲骨關節浸潤關節內注射市場規模和預測（2021 - 2031）、區域佔有率、趨勢和成長機會分析報告涵蓋範圍：按類型、最終用戶（醫院、骨科診所等）和國家/地區
市場調查報告書
商品編碼
1571399

歐洲骨關節浸潤關節內注射市場規模和預測（2021 - 2031）、區域佔有率、趨勢和成長機會分析報告涵蓋範圍：按類型、最終用戶（醫院、骨科診所等）和國家/地區

Europe Intra-Articular Injection for Osteoarticular Infiltrations Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, End User (Hospitals, Orthopedic Clinics, and Others), and Country
出版日期: | 出版商: The Insight Partners | 英文 92 Pages | 訂單完成後即時交付

價格

歐洲關節內注射骨關節浸潤市場規模預計將從2023年的9,743萬美元成長到2031年的1,5708萬美元；預計 2023 年至 2031 年複合年成長率為 6.2%。

治療骨關節炎的關節內注射是一種將藥物直接注射到受骨關節炎影響的關節的醫療程序。這種方法旨在減輕疼痛並改善關節功能。醫療保健專業人員和患者對這些注射的好處的認知不斷提高，加上對醫療保健基礎設施和創新的投資不斷增加，正在促進更多人獲得這些治療。骨關節炎盛行率的增加和注射技術的進步是導致歐洲骨關節浸潤關節內注射市場規模擴大的重要因素。然而，與關節內注射相關的副作用阻礙了歐洲關節內注射用於骨關節浸潤市場的成長。

關節內注射是治療骨關節浸潤的創新和新興領域之一。製造商參與各種臨床試驗，以確保創新藥物的安全性、有效性和可靠性。例如，2024年5月，瑞典公司Synartro發起了37,3至736萬美元的融資，用於骨關節炎候選藥物SYN321的臨床研究。目前正處於獲得歐盟 278 萬美元贈款的最後階段。此外，2023年4月，該公司獲得瑞典醫療產品局和瑞典倫理審查局的批准，啟動在研藥物SYN321的1/2a期首次人體臨床研究。該地區的其他市場參與者也在進行關節內注射的臨床試驗，這可以促進創新產品的開發。例如，2022年8月，德國Grunenthal公司在其樹脂毒素（RTX）全球臨床III期計畫中招募了第一位患者。 Grunenthal 在歐洲、美國、拉丁美洲、南非和日本的約 200 個地點進行了三項試驗，以調查成人關節內注射 RTX 的安全性和有效性。試驗中觀察到的結果主要集中在西安大略大學和麥克馬斯特大學 (WOMAC) 骨關節炎指數從基線到 52 週的身體功能和疼痛評分的改善。完成後，第三階段計劃旨在為 RTX 在歐洲、美國和日本提供行銷批准。該公司擬於2024年提交新藥申請，預示著RTX可能在2025年進入市場。幾年的成長。

基於類型的見解

根據類型，歐洲骨關節浸潤關節內注射市場分為 1 型膠原蛋白和透明質酸。到 2023 年，透明質酸細分市場將佔據歐洲最大的骨關節浸潤關節內注射市場。透明質酸注射療法的最新進展顯著擴大了生長軌跡。大力關注在市場上開發和推出新產品預計將支持該細分市場的成長，從而促進市場成長。

疾病管制與預防中心、世界衛生組織和國家生物技術資訊中心是在準備歐洲關節內注射骨關節浸潤市場報告時參考的主要和次要來源之一。

目錄

第 1 章：簡介

第 2 章：執行摘要

  • 主要見解

第 3 章：研究方法

  • 二次研究
  • 初步研究
    • 假設表述：
    • 宏觀經濟因素分析：
    • 顯影基數：
    • 數據三角測量：
    • 國家級資料：

第 4 章：歐洲關節內注射骨關節浸潤市場格局

  • 概述
  • PEST分析
  • 關於為什麼膠原蛋白注射比 HA 注射更好的資訊
  • 定價分析

第 5 章：歐洲骨關節浸潤關節內注射市場 - 主要市場動態

  • 歐洲骨關節浸潤關節內注射市場 - 主要市場動態
  • 市場促進因素
    • 骨關節炎盛行率上升
    • 注射技術的進步
  • 市場限制
    • 與關節內注射相關的副作用
  • 市場機會
    • 關節內注射治療骨關節浸潤的策略性舉措
  • 未來趨勢
    • 臨床試驗數量不斷增加
  • 促進因素和限制的影響：

第 6 章：歐洲關節內注射骨關節浸潤市場分析

  • 歐洲骨關節浸潤關節內注射市場收入，2021-2031年
  • 歐洲骨關節浸潤關節內注射市場預測與分析

第 7 章：歐洲骨關節浸潤關節內注射市場分析 - 按類型

  • 1 型膠原蛋白
  • 玻尿酸

第 8 章：歐洲骨關節浸潤關節內注射市場分析 - 按下最終用戶

  • 醫院
  • 骨科診所
  • 其他

第 9 章：歐洲骨關節浸潤關節內注射市場 - 國家分析

  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 歐洲其他地區

第 10 章：產業格局

  • 概述
  • 骨關節浸潤市場關節內注射的成長策略
  • 有機成長策略
    • 概述
  • 無機成長策略
    • 概述

第 11 章：公司簡介

  • Bioventus Inc
  • SEIKAGAKU CORPORATION
  • Maxigen Biotech Inc.
  • ?stem Medical Inc.
  • Sanofi SA
  • Ferring Pharmaceuticals
  • Fidia Pharma USA Inc.
  • Biotech Healthcare Group
  • Bioteck S.p.A.
  • I+MED

第 12 章：附錄

Product Code: TIPRE00039338

The Europe intra-articular injection for osteoarticular infiltrations market size is expected to grow from US$ 97.43 million in 2023 to US$ 157.08 million by 2031; it is projected to register a CAGR of 6.2% during 2023-2031.

Intra-articular injections for osteoarthritis are a medical procedure where medication is injected directly into a joint affected by osteoarthritis. This approach is intended to reduce pain and improve joint function. Increasing awareness among healthcare professionals and patients regarding the benefits of these injections, combined with increasing investment in healthcare infrastructure and innovation, is facilitating increased access to these treatments. The increasing prevalence of osteoarthritis and advancements in injection techniques are noteworthy factors contributing to the expansion of the Europe intra-articular injection for osteoarticular infiltrations market size. However, the side effects associated with intra-articular injections hinder the Europe intra-articular injection for osteoarticular infiltrations market growth.

Intra-articular injections are among the innovative and emerging fields of treatment for osteoarticular infiltrations. Manufacturers are involved in various clinical trials to ensure the safety, efficacy, and reliability of innovative drugs. For instance, in May 2024, the Swedish Company, Synartro, initiated a capital raise of between US$ 3.73 and 7.36 million to conduct a clinical study of the osteoarthritis candidate SYN321. It is in the final phase to secure an EU grant of US$ 2.78 million. Additionally, in April 2023, the company received approval from the Swedish Medical Products Agency and the Swedish Ethical Review Authority to start the phase 1/2a first-in-human clinical study of the investigational drug candidate SYN321. Other market players in the regions are also conducting clinical trials for intra-articular injections, which can lead to the development of innovative products. For instance, in August 2022, Grunenthal, a German company enrolled the first patient in its global clinical Phase III program for resiniferatoxin (RTX). Grunenthal has conducted three trials in ~200 locations across Europe, the US, Latin America, South Africa, and Japan to investigate the safety and effectiveness of intra-articular injections of RTX in adults. The outcomes observed in the trials mainly focus on an improvement in the physical function and pain score in the Western Ontario and McMaster Universities (WOMAC) osteoarthritis index from baseline to 52 weeks. Upon completion, the Phase III program is intended to provide marketing approval for RTX in Europe, the US, and Japan. The company intends to submit a new drug application in 2024, indicating the potential market entry of RTX in 2025. Therefore, the increasing number of clinical trials are expected to enhance the development of innovative products in the region, which, in turn, will contribute to the Europe intra-articular injection for osteoarticular infiltrations market growth in coming years.

Type-Based Insights

Based on type, the Europe intra-articular injection for osteoarticular infiltrations market is segmented into Type 1 collagen and hyaluronic acid. The hyaluronic acid segment held the largest Europe intra-articular injection for osteoarticular infiltrations market share in 2023 Hyaluronic acid injections are employed to treat knee pain in patients who were not responsive to other treatment options. Recent advancements in hyaluronic acid injection therapy have significantly expanded growth trajectory. A robust focus on developing and introducing novel products in the market is expected to support the growth of the segment, thereby contributing to market growth.

The Centers for Disease Control and Prevention, World Health Organization, and National Center for Biotechnology Information are among the primary and secondary sources referred to while preparing the Europe intra-articular injection for osteoarticular infiltrations market report.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
  • 4.3 Information on why collagen injections are better than HA injections
  • 4.4 Pricing Analysis

5. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Key Market Dynamics

  • 5.1 Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Key Market Dynamics
  • 5.2 Market Drivers
    • 5.2.1 Rising Prevalence of Osteoarthritis
    • 5.2.2 Advancements in Injection Techniques
  • 5.3 Market Restraints
    • 5.3.1 Side Effects Associated with Intra-Articular Injections
  • 5.4 Market Opportunities
    • 5.4.1 Strategic Initiatives in Intra-Articular Injection for Osteoarticular Infiltrations
  • 5.5 Future Trends
    • 5.5.1 Increasing Number of Clinical Trials
  • 5.6 Impact of Drivers and Restraints:

6. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Analysis

  • 6.1 Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Revenue (US$ Million), 2021-2031
  • 6.2 Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Forecast and Analysis

7. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Analysis - by Type

  • 7.1 Type 1 Collagen
    • 7.1.1 Overview
    • 7.1.2 Type 1 Collagen: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.2 Hyaluronic Acid
    • 7.2.1 Overview
    • 7.2.2 Hyaluronic Acid: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million)

8. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Analysis - by End User

  • 8.1 Hospitals
    • 8.1.1 Overview
    • 8.1.2 Hospitals: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.2 Orthopedic Clinics
    • 8.2.1 Overview
    • 8.2.2 Orthopedic Clinics: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.3 Others
    • 8.3.1 Overview
    • 8.3.2 Others: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million)

9. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Country Analysis

  • 9.1 Europe
    • 9.1.1 Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Countries
    • 9.1.2 Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Revenue and Forecast and Analysis - by Country
      • 9.1.2.1 Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Revenue and Forecast and Analysis - by Country
      • 9.1.2.2 Germany: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.2.2.1 Germany: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type
        • 9.1.2.2.2 Germany: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type 1 Collagen
        • 9.1.2.2.3 Germany: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by End User
      • 9.1.2.3 United Kingdom: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.2.3.1 United Kingdom: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type
        • 9.1.2.3.2 United Kingdom: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type 1 Collagen
        • 9.1.2.3.3 United Kingdom: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by End User
      • 9.1.2.4 France: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.2.4.1 France: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type
        • 9.1.2.4.2 France: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type 1 Collagen
        • 9.1.2.4.3 France: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by End User
      • 9.1.2.5 Italy: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.2.5.1 Italy: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type
        • 9.1.2.5.2 Italy: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type 1 Collagen
        • 9.1.2.5.3 Italy: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by End User
      • 9.1.2.6 Spain: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.2.6.1 Spain: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type
        • 9.1.2.6.2 Spain: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type 1 Collagen
        • 9.1.2.6.3 Spain: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by End User
      • 9.1.2.7 Denmark: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.2.7.1 Denmark: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type
        • 9.1.2.7.2 Denmark: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type 1 Collagen
        • 9.1.2.7.3 Denmark: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by End User
      • 9.1.2.8 Rest of Europe: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.2.8.1 Rest of Europe: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type
        • 9.1.2.8.2 Rest of Europe: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type 1 Collagen
        • 9.1.2.8.3 Rest of Europe: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by End User

10. Industry Landscape

  • 10.1 Overview
  • 10.2 Growth Strategies in Intra-Articular Injection For Osteoarticular Infiltrations Market
  • 10.3 Organic Growth Strategies
    • 10.3.1 Overview
  • 10.4 Inorganic Growth Strategies
    • 10.4.1 Overview

11. Company Profiles

  • 11.1 Bioventus Inc
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Products and Services
    • 11.1.4 Financial Overview
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 SEIKAGAKU CORPORATION
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Products and Services
    • 11.2.4 Financial Overview
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 Maxigen Biotech Inc.
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Products and Services
    • 11.3.4 Financial Overview
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 ?stem Medical Inc.
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Products and Services
    • 11.4.4 Financial Overview
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments
  • 11.5 Sanofi SA
    • 11.5.1 Key Facts
    • 11.5.2 Business Description
    • 11.5.3 Products and Services
    • 11.5.4 Financial Overview
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Developments
  • 11.6 Ferring Pharmaceuticals
    • 11.6.1 Key Facts
    • 11.6.2 Business Description
    • 11.6.3 Products and Services
    • 11.6.4 Financial Overview
    • 11.6.5 SWOT Analysis
    • 11.6.6 Key Developments
  • 11.7 Fidia Pharma USA Inc.
    • 11.7.1 Key Facts
    • 11.7.2 Business Description
    • 11.7.3 Products and Services
    • 11.7.4 Financial Overview
    • 11.7.5 SWOT Analysis
    • 11.7.6 Key Developments
  • 11.8 Biotech Healthcare Group
    • 11.8.1 Key Facts
    • 11.8.2 Business Description
    • 11.8.3 Products and Services
    • 11.8.4 Financial Overview
    • 11.8.5 SWOT Analysis
    • 11.8.6 Key Developments
  • 11.9 Bioteck S.p.A.
    • 11.9.1 Key Facts
    • 11.9.2 Business Description
    • 11.9.3 Products and Services
    • 11.9.4 Financial Overview
    • 11.9.5 SWOT Analysis
    • 11.9.6 Key Developments
  • 11.10 I+MED
    • 11.10.1 Key Facts
    • 11.10.2 Business Description
    • 11.10.3 Products and Services
    • 11.10.4 Financial Overview
    • 11.10.5 SWOT Analysis
    • 11.10.6 Key Developments

12. Appendix

  • 12.1 About The Insight Partners
  • 12.2 Glossary of Terms

List Of Tables

  • Table 1. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Segmentation
  • Table 2. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million)
  • Table 3. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 4. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million) - by Type 1 Collagen
  • Table 5. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 6. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million) - by Country
  • Table 7. Germany: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 8. Germany: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million) - by Type 1 Collagen
  • Table 9. Germany: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 10. United Kingdom: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 11. United Kingdom: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million) - by Type 1 Collagen
  • Table 12. United Kingdom: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 13. France: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 14. France: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million) - by Type 1 Collagen
  • Table 15. France: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 16. Italy: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 17. Italy: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million) - by Type 1 Collagen
  • Table 18. Italy: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 19. Spain: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 20. Spain: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million) - by Type 1 Collagen
  • Table 21. Spain: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 22. Denmark: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 23. Denmark: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million) - by Type 1 Collagen
  • Table 24. Denmark: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 25. Rest of Europe: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 26. Rest of Europe: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million) - by Type 1 Collagen
  • Table 27. Rest of Europe: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 28. Recent Organic Growth Strategies in Intra-Articular Injection For Osteoarticular Infiltrations Market
  • Table 29. Recent Inorganic Growth Strategies in the Intra-Articular Injection For Osteoarticular Infiltrations Market
  • Table 30. Glossary of Terms, Europe Intra-Articular Injection For Osteoarticular Infiltrations Market

List Of Figures

  • Figure 1. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Segmentation, by Country
  • Figure 2. PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Revenue (US$ Million), 2021-2031
  • Figure 5. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Share (%) - by Type, 2023 and 2031
  • Figure 6. Type 1 Collagen: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 7. Hyaluronic Acid: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Share (%) - by End User, 2023 and 2031
  • Figure 9. Hospitals: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 10. Orthopedic Clinics: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 11. Others: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 12. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Key Countries, 2023 and 2031 (%)
  • Figure 13. Germany: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 14. United Kingdom: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 15. France: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 16. Italy: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 17. Spain: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 18. Denmark: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 19. Rest of Europe: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 20. Growth Strategies in Intra-Articular Injection For Osteoarticular Infiltrations Market